Clinical Trials Logo

Clinical Trial Summary

Phase II clinical trial assessing efficacy and toxicity of pretargeted radioimmunotherapy using anti-CEAxanti-DTPA bispecific antibody and di-DTPA-131I peptide in patients with reccurrence of medullary thyroid carcinoma (abnormal calcitonin level and biomarkers doubling time lower than 5 years)


Clinical Trial Description

n/a


Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Factorial Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00467506
Study type Interventional
Source Nantes University Hospital
Contact
Status Completed
Phase Phase 2
Start date May 2004
Completion date January 2011

See also
  Status Clinical Trial Phase
Completed NCT00537095 - Efficacy and Safety of Vandetanib (ZD6474) in Patients With Metastatic Papillary or Follicular Thyroid Cancer Phase 2
Recruiting NCT04139096 - Genetic Susceptibility to Radiation Induced Thyroid Cancer
Completed NCT00754182 - Subcuticular Suture Versus Synthetic Glue in Thyroidectomy Incision N/A
Completed NCT00094055 - Study of the Anti-angiogenesis Agent AG-013736 in Patients With Metastatic Thyroid Cancer Phase 2
Completed NCT00148213 - Clinical Evaluation of a New Highly Sensitive Thyroglobulin Assay in Differentiated Thyroid Carcinoma N/A
Recruiting NCT06398795 - Dual-port Trans-subclavian Thyroid Endoscopic Surgery N/A
Recruiting NCT01005654 - Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms
Active, not recruiting NCT05579782 - Assessing Benefits of NIRAF Detection for Identifying Parathyroid Glands During Total Thyroidectomy N/A
Completed NCT01437254 - To Compare Safety and the General Imaging Pattern of Cyclotron Produced Technetium vs. Generator Produced Technetium in Patients With Thyroid Cancer Phase 1
Recruiting NCT03160274 - Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions
Completed NCT00984282 - Nexavar® Versus Placebo in Locally Advanced/Metastatic RAI-Refractory Differentiated Thyroid Cancer Phase 3
Completed NCT01292044 - The Role of Elastography in the Diagnosis of Thyroid Nodules N/A
Terminated NCT04644315 - A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors Phase 2
Active, not recruiting NCT02418247 - Minimize Radioactive Iodine Ablation Of Remnant Thyroid in Differentiated Thyroid Cancer Phase 2/Phase 3
Completed NCT02430714 - Post-marketing Surveillance of Lenvatinib Mesylate (Lenvima Capsule) in Patients With Unresectable Thyroid Cancer (Study LEN01T)
Recruiting NCT04396912 - Post-thyroidectomy Vocal Cord Paralysis Along With Hypocalcemia: STROBE - Guided Prospective Cohort
Enrolling by invitation NCT04411290 - Malignancy Predictors, Bethesda and TI-RADS Scores Correlated With Final Histopathology in Thyroid Diseases
Recruiting NCT04410601 - Post-thyroidectomy Dysphagia: An International Multicentric CONSORT - Compatible RCT N/A
Completed NCT03469310 - Minimizing Narcotic Analgesics After Endocrine Surgery Phase 4
Completed NCT03871387 - The Effects of Deep Neuromuscular Blockade During Robot-assisted Transaxillary Thyroidectomy on Postoperative Pain and Sensory Change N/A